Supriya
SUPRIYA.NSSupriya Lifescience Limited Price (SUPRIYA.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
80,482,800
(0)%Revenue and Profitability
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,129,139,999 | 2,778,400,000 | 3,116,450,000 | 3,853,650,000 | 5,193,740,000 | 4,609,380,000 | 5,703,700,000 |
| Net Income | 87,280,000 | 394,240,000 | 734,030,000 | 1,235,930,000 | 1,518,100,000 | 898,570,000 | 1,191,140,000 |
| FCF USD | 125,220,000 | 417,270,000 | 915,370,000 | 316,890,000 | -111,030,000 | -422,130,000 | -323,480,000 |
| OCF USD | 174,520,000 | 486,720,000 | 1,160,620,000 | 799,300,000 | 488,010,000 | 661,870,000 | 1,133,070,000 |
Financial Health - DEBT
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.19 | 0.05 | 0.01 | 0.01 | 0.04 | 0.04 |
| D/E | 2.39 | 0.98 | 0.57 | 0.27 | 0.04 | 0.03 | 0.01 |
| CA/CL | 0.82 | 0.99 | 1.27 | 1.82 | 4.99 | 4.85 | 5.17 |
| TA/TL | 1.29 | 1.59 | 1.80 | 2.52 | 6.17 | 6.79 | 8.70 |
| Total Debt | 1,303,730,000 | 923,690,000 | 845,200,000 | 721,940,000 | 274,150,000 | 224,680,000 | 54,880,000 |
Management Performance
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| ROIC | 5.18% | 21.11% | 31.75% | 33.27% | 22.78% | 11.50% | 13.62% |
| ROE | 15.97% | 42.03% | 49.20% | 45.96% | 24.66% | 12.85% | 14.61% |
| ROA | 0.00% | 22.57% | 28.60% | 37.55% | 28.21% | 15.05% | 12.93% |
| NM % | 4.10% | 14.19% | 23.55% | 32.07% | 29.23% | 19.49% | 20.88% |
| FCF / R% | 0.00% | 15.02% | 29.37% | 8.22% | -2.14% | -9.16% | -5.67% |
| FCF / NI% | 143.47% | 73.07% | 95.13% | 18.93% | -5.36% | -34.18% | -27.16% |
| Operating Margin (OM) | 0.00 | 0.28 | 0.43 | 0.66 | 0.77 | 1.05 | 1.05 |
Per Share
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| EPS | 1.19 | 15.43 | 10.03 | 16.89 | 18.86 | 11.16 | 14.80 |
| SPS | 29.09 | 108.75 | 42.59 | 52.66 | 64.53 | 57.27 | 70.87 |
| OCPS | 2.38 | 19.05 | 15.86 | 10.92 | 6.06 | 8.22 | 14.08 |
| FCPS | 1.71 | 16.33 | 12.51 | 4.33 | -1.38 | -5.24 | -4.02 |
| BVPS | 7.47 | 36.71 | 20.39 | 36.75 | 76.50 | 86.91 | 101.31 |
Per Share - CAGR
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| CAGR-EPS | 1.19 | 15.43 | 10.03 | 16.89 | 18.86 | 11.16 | 14.80 |
| CAGR-SPS | 29.09 | 108.75 | 42.59 | 52.66 | 64.53 | 57.27 | 70.87 |
| CAGR-OCPS | 2.38 | 19.05 | 15.86 | 10.92 | 6.06 | 8.22 | 14.08 |
| CAGR-FCPS | 1.71 | 16.33 | 12.51 | 4.33 | -1.38 | -5.24 | -4.02 |
| CAGR-BVPS | 7.47 | 36.71 | 20.39 | 36.75 | 76.50 | 86.91 | 101.31 |